Global Prevalence of COVID-19-Associated Mucormycosis (CAM): Living Systematic Review and Meta-Analysis
Mucormycosis, a secondary fungal infection, gained much attention in the ongoing COVID-19 pandemic. This deadly infection has a high all-cause mortality rate and imposes a significant economic, epidemiological, and humanistic burden on the patients and healthcare system. Evidence from the published...
Enregistré dans:
Auteurs principaux: | Salman Hussain, Abanoub Riad, Ambrish Singh, Jitka Klugarová, Benny Antony, Hasanul Banna, Miloslav Klugar |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b9d61247f58a4c9ca9fedacc70a33eb8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China
par: Junyan Qu, et autres
Publié: (2021) -
Rhino-orbito-cerebral Mucormycosis: Pictorial Review
par: Vivek Pai, et autres
Publié: (2021) -
Mucormycosis in Hematologic Malignancies: Clinical Follow-Up and Treatment Results
par: Nagehan Didem Sarı, et autres
Publié: (2021) -
Inhibition of EGFR Signaling Protects from Mucormycosis
par: Tonya N. Watkins, et autres
Publié: (2018) -
Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
par: F. Yuan, et autres
Publié: (2021)